GC Biopharma’s Alyglo secures FDA approval for primary humoral immunodeficiency
Manufactured from pooled human plasma from American donors, Alyglo is a liquid solution with 10% immunoglobulin G (100…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Dec 23
Manufactured from pooled human plasma from American donors, Alyglo is a liquid solution with 10% immunoglobulin G (100…
19 Dec 23
Most of these products have been developed by Biocon Biologics and are being manufactured at its world-class facilities…
18 Dec 23
The recommendation will be considered by the European Commission in deciding whether to allow Hyqvia for CIDP to…
18 Dec 23
CymaBay seeks approval for PBC management including pruritus in adults without cirrhosis or with compensated cirrhosis who are…
18 Dec 23
The divestiture will be executed through a third-party sale or capital markets transaction
18 Dec 23
Proceeds from the Series B financing will be used to advance Totus' clinical program, expand the pipeline, and…
15 Dec 23
MedLM is now accessible to Google Cloud users in the US, with a designated general availability on the…
15 Dec 23
The approval was based on the data from an open-label, randomised, active-controlled LITESPARK-005 clinical trial in which Welireg…
15 Dec 23
Further establishes Pfizer as a leading oncology company poised to accelerate the next generation of breakthrough treatments for…
14 Dec 23
The latest designation comes after Investigational New Drug (IND) clearance for KYV-101 for use in Kyverna's KYSA-6 Phase…